BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Arctic Vision (Shanghai) Biotechnology Co. Ltd.

Headquarters: Shanghai, China
Year Founded: 2019
Status: Private

BioCentury | Aug 18, 2021
Deals

Quick Takes Aug. 17: InnoCare gains China rights to Incyte’s Monjuvi

Plus: Neuroblastoma approval for BeiGene, priority review for Agios’ mitapivat, Arctic Vision, Vectura, AnaptysBio and more
BioCentury | Mar 11, 2021
Deals

March 10 Quick Takes: Eddy Wu’s Arctic Vision raises $100M; plus Touchlight, NeoPhore, MediciNova-BARDA and Neurelis

Arctic Vision (Shanghai) Biotechnology Co. Ltd. raised $100 million in a series B round led by Loyal Valley Capital. The funds will go in part to support the company’s trio of late-stage
BioCentury | Aug 29, 2020
Emerging Company Profile

Arctic Vision sets sights on China’s innovation gap in ophthalmology

A veteran of MNCs, Eddy Wu launches biotech to in-license and discover eye therapies
Items per page:
1 - 3 of 3